1. Academic Validation
  2. The environmental pollutant F-53B accelerates triple-negative breast cancer progression through metabolic reprogramming

The environmental pollutant F-53B accelerates triple-negative breast cancer progression through metabolic reprogramming

  • Ecotoxicol Environ Saf. 2025 Dec 15:309:119536. doi: 10.1016/j.ecoenv.2025.119536.
Shiyan Lao 1 Jianlong Xie 2 Yongfang Ou 3 Haoyong Liu 4 Qiujuan Fu 5 Jiahuan Wu 6 Lingling Qin 7 Ruiyin Li 7 Kaiqi Zeng 6 Sihan Wang 6 Lingdiao Zeng 8
Affiliations

Affiliations

  • 1 Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, China; Emergency Center, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, China. Electronic address: [email protected].
  • 2 Department of Thoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China. Electronic address: [email protected].
  • 3 Pathology Diagnosis Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China. Electronic address: [email protected].
  • 4 Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, China.
  • 5 Pathology Diagnosis Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China.
  • 6 First Clinical College, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
  • 7 Pathology Diagnosis Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China; First Clinical College, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
  • 8 Department of Thyroid and Breast Surgery, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524003, China. Electronic address: [email protected].
Abstract

Following the ban on perfluorooctane sulfonate (PFOS), the use of chlorinated polyfluoroalkyl ether sulfonates (Cl-PFESA, known commercially as F-53B) has surged significantly in China. Numerous studies indicate that F-53B is increasingly detected in diverse environmental media, Animals, and humans, with both its concentration and detection frequency rising annually. Humans can be exposed to F-53B through respiration, skin contact, drinking water, and dietary intake. Triple-negative breast Cancer (TNBC), a highly malignant subtype with a poor prognosis, is experiencing a rising incidence rate, with environmental pollutants significantly linked to its onset and progression. This study utilized TNBC cells as a model to assess the impact of F-53B on breast Cancer. Our experimental results demonstrated that F-53B could promote the proliferation of TNBC, as verified by CCK8 assay and the detection of marker molecules for cell proliferation. Further studies revealed that F-53B could increase ATP production and glucose uptake in TNBC cells. Our findings also indicated that F-53B could enhance glycolysis, as evidenced by the expression levels of PKM2, GLUT1, HK2, and LDHA. Our investigation into the molecular mechanism of F-53B in breast Cancer revealed that F-53B stabilizes HIF-1α protein levels. We found that F-53B inhibits the HIF-α and VHL interaction, preventing HIF-1α degradation. Consequently, the expression of glycolysis-related Enzymes increased. In conclusion, the present study identified a close association between F-53B and the onset and progression of TNBC, providing important evidence for investigating the toxicological mechanism of F-53B.

Keywords

Breast Cancer; F-53B; HIF-1α; PKM2.

Figures
Products